In a recent large-scale analysis utilising the 13,037 participants enrolled in the NBR study, of which 1148 patients were recruited to the PAH domain, we discovered KDR as a novel PAH candidate gene [24,30] utilising the Bayesian model comparison method, BeviMed [64], and deep phenotype data. Here, KDR is linked to pulmonary arterial hypertension.